AMENDMENT NO. 2 TO DEPOSIT AGREEMENTDeposit Agreement • November 9th, 2006 • DR Reddys Laboratories LTD • Pharmaceutical preparations • New York
AMENDMENT NO. 2 dated as of November , 2006 (the "Amendment") to the Deposit Agreement dated as of April 10, 2001 (the "Deposit Agreement"), among Dr. Reddy's Laboratories Limited (the "Company"), incorporated under the laws of the Republic of India, JPMorgan Chase Bank, N.A., as depositary (the "Depositary"), and all Holders from time to time of American Depositary Receipts ("ADRs") issued thereunder.
Dated March 16, 2011 DEBENTURE TRUST DEED amongst Dr. REDDY’S LABORATORIES LIMITED (as the Issuer) and IDBI TRUSTEESHIP SERVICES LIMITED (as the Debenture Trustee)DR Reddys Laboratories LTD • July 20th, 2011 • Pharmaceutical preparations
ASSET PURCHASE AGREEMENT BETWEEN TEVA PHARMACEUTICAL INDUSTRIES LTD. AND DR. REDDY’S LABORATORIES S.A. DATED AS OF JUNE 10, 2016Asset Purchase Agreement • June 19th, 2017 • DR Reddys Laboratories LTD • Pharmaceutical preparations • New York
THIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of June 10, 2016 (the “Effective Date”), is made by and between Dr. Reddy’s Laboratories S.A., a company organized under the laws of Switzerland (“Buyer”), and Teva Pharmaceutical Industries Ltd., an Israeli corporation, acting directly or through its Affiliates (“Seller”).
ContractDR Reddys Laboratories LTD • June 30th, 2021 • Pharmaceutical preparations
CERTAIN IDENTIFIED INFORMATION MARKED WITH [***] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND IS OF THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL.
ContractDR Reddys Laboratories LTD • June 30th, 2021 • Pharmaceutical preparations
CERTAIN IDENTIFIED INFORMATION MARKED WITH [***] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND IS OF THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL.
ASSET PURCHASE AGREEMENT BETWEEN WATSON LABORATORIES, INC. AND DR. REDDY’S LABORATORIES S.A. DATED AS OF JUNE 10, 2016Asset Purchase Agreement • June 19th, 2017 • DR Reddys Laboratories LTD • Pharmaceutical preparations • New York
THIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of June 10, 2016 (the “Effective Date”), is made by and between Dr. Reddy’s Laboratories S.A., a company organized under the laws of Switzerland (“Buyer”), and Watson Laboratories Inc., a Nevada corporation (“Seller”).
To be stamped on Stamp Paper of Rs. 300 if stamped in Mumbai] LIQUIDITY FACILITY SERVICES AGREEMENTLiquidity Facility Services Agreement • July 20th, 2011 • DR Reddys Laboratories LTD • Pharmaceutical preparations
DR. REDDY’S LABORATORIES LIMITED, a company registered under the Companies Act, 1956, with its registered office at 7-1-27, Ameerpet, Hyderabad, Andhra Pradesh (hereinafter referred to as the “Company” which expression shall be deemed to include its successors and permitted assigns);
DR. REDDY’S LABORATORIES LIMITED [13,500,000] American Depositary Shares Each Representing One Equity Share par value Rs. 5 per Equity Share UNDERWRITING AGREEMENT [November 16], 2006DR Reddys Laboratories LTD • November 16th, 2006 • Pharmaceutical preparations • New York
Merrill Lynch, Pierce, Fenner & Smith Incorporated Citigroup Global Markets Inc. as Representatives of the several Underwriters
ContractDR Reddys Laboratories LTD • June 30th, 2021 • Pharmaceutical preparations
CERTAIN IDENTIFIED INFORMATION MARKED WITH [***] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND IS OF THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL.
DATED FEBRUARY 12,2020 BUSINESS TRANSFER AGREEMENT WOCKHARDT LIMITED as the Seller AND DR. REDDY’S LABORATORIES LIMITED as the PurchaserBusiness Transfer Agreement • June 30th, 2021 • DR Reddys Laboratories LTD • Pharmaceutical preparations
CERTAIN IDENTIFIED INFORMATION MARKED WITH [***] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND IS OF THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL.
